Ephedrine HydrochlorideCAS# 50-98-6 |
- Pseudoephedrine Hydrochloride; Threo-Ephedrine Hydrochloride
Catalog No.:BCC8241
CAS No.:345-78-8
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 50-98-6 | SDF | Download SDF |
PubChem ID | 65326 | Appearance | Powder |
Formula | C10H16ClNO | M.Wt | 201.7 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (1R,2S)-2-(methylamino)-1-phenylpropan-1-ol;hydrochloride | ||
SMILES | CC(C(C1=CC=CC=C1)O)NC.Cl | ||
Standard InChIKey | BALXUFOVQVENIU-GNAZCLTHSA-N | ||
Standard InChI | InChI=1S/C10H15NO.ClH/c1-8(11-2)10(12)9-6-4-3-5-7-9;/h3-8,10-12H,1-2H3;1H/t8-,10-;/m0./s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Ephedrine Hydrochloride Dilution Calculator
Ephedrine Hydrochloride Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.9579 mL | 24.7893 mL | 49.5786 mL | 99.1572 mL | 123.9465 mL |
5 mM | 0.9916 mL | 4.9579 mL | 9.9157 mL | 19.8314 mL | 24.7893 mL |
10 mM | 0.4958 mL | 2.4789 mL | 4.9579 mL | 9.9157 mL | 12.3946 mL |
50 mM | 0.0992 mL | 0.4958 mL | 0.9916 mL | 1.9831 mL | 2.4789 mL |
100 mM | 0.0496 mL | 0.2479 mL | 0.4958 mL | 0.9916 mL | 1.2395 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Floxuridine
Catalog No.:BCC1187
CAS No.:50-91-9
- Thymidine
Catalog No.:BCN5622
CAS No.:50-89-5
- Ascorbic acid
Catalog No.:BCN2207
CAS No.:50-81-7
- Aspirin (Acetylsalicylic acid)
Catalog No.:BCC2097
CAS No.:50-78-2
- Actinomycin D
Catalog No.:BCC2385
CAS No.:50-76-0
- 1,3:2,4-Di-p-methylbenyliedene sorbitol
Catalog No.:BCC4847
CAS No.:54686-97-4
- 5-Hydroxytryptamine
Catalog No.:BCC9204
CAS No.:50-67-9
- Niclosamide
Catalog No.:BCC5081
CAS No.:50-65-7
- Chloroquine diphosphate
Catalog No.:BCC3915
CAS No.:50-63-5
- Oxytocin
Catalog No.:BCC5435
CAS No.:50-56-6
- Reserpine
Catalog No.:BCN4960
CAS No.:50-55-5
- Estradiol Benzoate
Catalog No.:BCC4779
CAS No.:50-50-0
- D-(+)-Glucose
Catalog No.:BCN1259
CAS No.:50-99-7
- Nordihydroguaiaretic acid
Catalog No.:BCC1805
CAS No.:500-38-9
- L-Mimosine
Catalog No.:BCC5450
CAS No.:500-44-7
- Apoatropine
Catalog No.:BCN1869
CAS No.:500-55-0
- Convolamine
Catalog No.:BCN1905
CAS No.:500-56-1
- Yangonin
Catalog No.:BCN3565
CAS No.:500-62-9
- Kawain
Catalog No.:BCN3564
CAS No.:500-64-1
- Rhapontigenin
Catalog No.:BCN3515
CAS No.:500-65-2
- Olivetol
Catalog No.:BCN4629
CAS No.:500-66-3
- 3,5-Dimethoxyphenol
Catalog No.:BCN7198
CAS No.:500-99-2
- Rilpivirine
Catalog No.:BCC1897
CAS No.:500287-72-9
- GANT61
Catalog No.:BCC1090
CAS No.:500579-04-4
Rocuronium anaphylaxis in a 7-year-old boy during the induction of anesthesia.[Pubmed:30938264]
Immunol Med. 2018 Jun;41(2):85-88.
We report a case of rocuronium-induced anaphylaxis in a previously healthy 7-year-old boy. The first presenting sign of anaphylaxis was bronchospasm, appearing 11 min after he received intravenous doses of rocuronium (1 mg/kg) (Eslax((R)), MSD Co. Ltd., Tokyo, Japan), propofol (2 mg/kg), and cefazolin sodium (25 mg/kg). After the administration of adrenalin and Ephedrine Hydrochloride, bronchospasm resolved, and the vital signs became stable. Percutaneous pinning of his left humeral supracondylar fracture was performed without problems. The next day, he was successfully liberated from the ventilator support and discharged on the fifth hospital day. On the 76th postoperative day, we performed intradermal tests of rocuronium, propofol, and cefazolin. It showed that diluted rocuronium alone induced 14 mm of flare and 8 mm of wheal within 5 min, both of which disappeared within 15 min after the intradermal injection. The reaction was too quick to mention the possible contribution of rocuronium-specific IgE. His rapid reaction at the rocuronium skin test and anaphylactic reaction upon the first exposure to this drug may highlight the association of rocuronium anaphylaxis with IgE independent mast cell stimulation through mas-related G-protein coupled receptor X2 (MRGPRX2 receptor).